Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript

被引：0

作者：

A Tchirkov

J-L Couderc

B Périssel

C Goumy

A Regnier

N Uhrhammer

P Verrelle

M Berger

机构：

[1] Centre Jean Perrin,

[2] Service de Cytogénétique Médicale,undefined

[3] CHU – Faculté de Médecine,undefined

[4] UMR 384 INSERM,undefined

[5] Service de Médecine Interne,undefined

[6] CH,undefined

[7] Hématologie,undefined

[8] Faculté de Médecine,undefined

来源：

Leukemia | 2006年 / 20卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：167 / 168

页数：1

共 50 条

[41] Dose modification of imatinib by monitoring the level of BCR-ABL transcript in chronic mvelogenous leukemia [J].

Ishikawa, Izumi ;

Kato, Chiaki ;

Harigae, Hideo ;

Sugawara, Tomohiro ;

Tomiya, Yasuo ;

Yamada, Minami ;

Ishizawa, Kenichi ;

Kameoka, Junichi ;

Miyamura, Koichi ;

Sasaki, Takeshi .

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 210 (04) :355-363

[42] Interaction of a novel signaling protein (AHI-1) with BCR-ABL modulates BCR-ABL transforming activity and imatinib response of chronic myeloid leukemia progenitor cells [J].

Zhao, Yuri ;

Zhou, Leon ;

Ringrose, Ashley ;

Lin, Ann E. -J. ;

Kennah, Erin ;

Sheng, Guoqing ;

Li, Xiao-Jiang ;

Turhan, Ali ;

Jiang, Xiaoyan .

BLOOD, 2007, 110 (11) :144A-144A

[43] Translisin recognition site sequences flank translocation breakpoints in a Philadelphia chromosome positive chronic myeloid leukemia patient expressing a novel type of chimeric BCR-ABL transcript (E8-INT-A2) [J].

Martinelli, G ;

Terragna, C ;

Amabile, M ;

Montefusco, V ;

Testoni, N ;

Ottaviani, E ;

de Vivo, A ;

Mianulli, A ;

Trabacchi, E ;

Saglio, G ;

Tura, S .

LEUKEMIA, 1999, 13 (10) :1635-1637

[44] Translisin recognition site sequences flank translocation breakpoints in a Philadelphia chromosome positive chronic myeloid leukemia patient expressing a novel type of chimeric BCR-ABL transcript (E8-INT-A2) [J].

G Martinelli ;

C Terragna ;

M Amabile ;

V Montefusco ;

N Testoni ;

E Ottaviani ;

A de Vivo ;

A Mianulli ;

E Trabacchi ;

G Saglio ;

S Tura .

Leukemia, 1999, 13 :1635-1637

[45] Translisin recognition site sequences flank translocation breakpoints in a Philadelphia chromosome positive chronic myeloid leukemia patient expressing a novel type of chimeric BCR-ABL transcript (E8-INT-A2) [J].

Martinelli, G ;

Terragna, C ;

Amabile, M ;

Montefusco, V ;

Testoni, N ;

Ottaviani, E ;

De Vivo, A ;

Mianulli, A ;

Saglio, S ;

Tura, S .

BLOOD, 1998, 92 (10) :93A-93A

[46] Molecular response to imatinib is achieved faster in chronic myeloid leukemia (CML) patients harboring the e14a2 BCR-ABL fusion transcript compared to those harboring e13a2 [J].

Hanfstein, B. ;

Erben, P. ;

Agrawal, M. ;

Schnittger, S. ;

Ernst, T. ;

Schenk, T. ;

Hofmann, W-K ;

Hehlmann, R. ;

Hochhaus, A. ;

Mueller, M. C. .

ONKOLOGIE, 2010, 33 :145-145

[47] IMPACT OF BCR-ABL MUTATIONS ON RESPONSE TO DASATINIB IN ELDERLY CHRONIC MYELOID LEUKEMIA PATIENTS RESISTANT TO IMATINIB [J].

Tiribelli, M. ;

Latagliata, R. ;

Breccia, M. ;

Luciano, L. ;

Castagnetti, F. ;

Gozzini, A. ;

Cambrin, G. Rege ;

Annunziata, M. ;

Stagno, F. ;

Pregno, P. ;

Albano, F. ;

Abruzzese, F. ;

Musto, P. ;

Sora, F. ;

Ferrero, D. ;

Montefusco, E. ;

Cavazzini, F. ;

Binotto, G. ;

Fanin, R. ;

Pane, F. ;

Rosti, G. ;

Santini, V. ;

Fava, C. ;

Alimena, G. ;

Vigneri, P. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 :347-347

[48] Imatinib failure and response to dasatinib in a patient with chronic myeloid leukemia in blast crisis and a novel, nine-nucleotide BCR-ABL insertion mutation [J].

Sigl, M. ;

Spoerl, S. ;

Schnittger, S. ;

Meissner, J. ;

Rummelt, C. ;

Peschel, C. ;

Duyster, J. ;

Ho, A. D. ;

von Bubnoff, N. .

BLOOD CANCER JOURNAL, 2013, 3 :e104-e104

[49] Novel potent inhibitor of Bcr-Abl mutated imatinib resistant chronic myeloid leukemia cell lines [J].

Joshi, Kalpana S. ;

Manohar, Sonal ;

Jalota-Badhwar, Archana ;

Sonawane, Vinay ;

Damre, Anagha ;

Sivakumar, Meenakshi ;

Sharma, Somesh .

CANCER RESEARCH, 2012, 72

[50] Targeting the imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia through a novel BCR-ABL inhibitor [J].

Gupta, Pranav ;

Kathawala, Rishil ;

Wei, Liuya ;

Wang, Fang ;

Wang, XiaoKun ;

Druker, Brian J. ;

Fu, Li-Wu ;

Chen, Zhe-Sheng .

CANCER RESEARCH, 2017, 77

← 1 2 3 4 5 →